Orgenesis Inc. (ORGS)

USD 2.4

(10.6%)

Revenue Summary of Orgenesis Inc.

  • Orgenesis Inc.'s latest annual revenue in 2023 was 530 Thousand USD , down -98.53% from previous year.
  • Orgenesis Inc.'s latest quarterly revenue in 2024 Q2 was 246 Thousand USD , up 74.47% from previous quarter.
  • Orgenesis Inc. reported a annual revenue of 36.02 Million USD in annual revenue 2022, up 1.47% from previous year.
  • Orgenesis Inc. reported a annual revenue of 35.5 Million USD in annual revenue 2021, up 363.96% from previous year.
  • Orgenesis Inc. reported a quarterly revenue of 246 Thousand USD for 2024 Q2, up 74.47% from previous quarter.
  • Orgenesis Inc. reported a quarterly revenue of 110 Thousand USD for 2023 Q3, down -98.42% from previous quarter.

Annual Revenue Chart of Orgenesis Inc. (2023 - 2008)

Historical Annual Revenue of Orgenesis Inc. (2023 - 2008)

Year Revenue Revenue Growth
2023 530 Thousand USD -98.53%
2022 36.02 Million USD 1.47%
2021 35.5 Million USD 363.96%
2020 7.65 Million USD -76.99%
2019 33.25 Million USD 78.27%
2018 18.65 Million USD 84.9%
2017 10.08 Million USD 57.71%
2016 6.39 Million USD 115.1%
2015 2.97 Million USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%

Peer Revenue Comparison of Orgenesis Inc.

Name Revenue Revenue Difference
America Great Health 204.3 Thousand USD -159.412%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
Biora Therapeutics, Inc. 4000.00 USD -13150.0%
Bio-Path Holdings, Inc. - USD -Infinity%
Better Therapeutics, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD 16.285%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Evolutionary Genomics, Inc. - USD -Infinity%
Finch Therapeutics Group, Inc. 107 Thousand USD -395.327%
Galera Therapeutics, Inc. - USD -Infinity%
Innovation1 Biotech Inc. - USD -Infinity%
Kiromic BioPharma, Inc. - USD -Infinity%
Molecular Templates, Inc. 57.3 Million USD 99.075%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD -707.287%
NexImmune, Inc. - USD -Infinity%
Panbela Therapeutics, Inc. - USD -Infinity%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 62.83 Million USD 99.157%
Statera Biopharma, Inc. - USD -Infinity%
TRACON Pharmaceuticals, Inc. 12.04 Million USD 95.6%
Trevena, Inc. 3.12 Million USD 83.04%
Vaxxinity, Inc. - USD -Infinity%
Vaccinex, Inc. 570 Thousand USD 7.018%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
ZIVO Bioscience, Inc. 27.65 Thousand USD -1816.817%